We are the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation. Our public benefit purpose is to provide a brighter future for patients through the development of novel pharmaceutical therapies; and technologies that expand the availability of transplantable organs. United Therapeutics (Nasdaq: UTHR) seeks to travel down the corridors of indifference to develop treatments for rare, deadly diseases. We were founded in 1996 by a family seeking a cure for their daughter’s pulmonary arterial hypertension (PAH). Today, we have six FDA-approved therapies that treat PAH, pulmonary hypertension associated with interstitial lung disease (PH-ILD) and neuroblastoma, a rare pediatric cancer. Our near-term pipeline seeks to develop additional therapies for PAH and pulmonary fibrosis (PF). The cure for end-stage life-threatening diseases like PAH, PH-ILD, PF, and many others is an organ transplant, but only a small percentage of donated organs are available to address the vast need. For this reason, we are working to create manufactured organs to address the shortage of kidneys, hearts, lungs, and livers available for transplant. We believe an unlimited supply of tolerable, transplantable organs will eliminate the transplant waiting list and cure end-stage organ diseases for which transplant is not currently an option. The selected intern will need to report onsite at the Silver Spring, MD office for the entire duration of the program which runs from May through August 2026. United Therapeutics does not provide housing or transportation. A stipend for relocation assistance may be provided on a case-by-case basis. Here at Lung Bioengineering (a wholly owned subsidiary of United Therapeutics), our mission is to increase the availability and suitability of organs for transplant. Ex-Vivo Lung Perfusion (EVLP) is a procedure used by transplant teams to evaluate lungs outside the body, providing essential information on lungs that may not initially appear suitable for transplant. Our EVLP Clinical Specialists play a vital role in this process, working closely with transplant surgeons to provide hands-on assessments and detailed data on the condition of the lungs. This crucial information helps surgeons determine the suitability of lungs for transplantation. In this internship, you'll have opportunities to gain clinical experience supporting our EVLP procedure as well as support data analysis projects and gain insight into the use of Machine Learning to support EVLP efforts.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Intern
Education Level
No Education Listed
Number of Employees
1,001-5,000 employees